Mesoblast Limited Named 2009 North American Emerging Company By Frost & Sullivan

January 6, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Melbourne, Jan 6, 2009 (ABN Newswire) - Regenerative medicine company Mesoblast Limited (ASX:MSB)(PINK:MBLTY) announced today that it has received the 2009 Frost & Sullivan Emerging Company Award in the United States Soft Tissue Repair market.

Twitter
LinkedIn
Facebook
Email
Print

Asia Australia